Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126161151 | 12616115 | 1 | I | 20160720 | 20160802 | 20160802 | EXP | BE-VALIDUS PHARMACEUTICALS LLC-BE-2016VAL002321 | VALIDUS | VAN HERCK M, CLAEYS M, VAN DER WIJST E, VORLAT A, VRINTS C. SINUS BRADYCARDIA AND ACUTE RENAL FAILURE. ACTA CLIN BELG. 2015;70(3 SUPPL):20-21 | 64.00 | YR | M | Y | 0.00000 | 20160802 | OT | BE | BE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126161151 | 12616115 | 1 | PS | BUMETANIDE. | BUMETANIDE | 1 | Unknown | 2.5 MG/DAY | U | 18225 | 2.5 | MG | |||||||
126161151 | 12616115 | 2 | SS | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Unknown | 80 MG/DAY | U | 0 | 80 | MG | |||||||
126161151 | 12616115 | 3 | SS | PERINDOPRIL | PERINDOPRIL | 1 | Unknown | 5 MG/DAY | Y | U | 0 | 5 | MG | ||||||
126161151 | 12616115 | 4 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 2X850 MG/DAY | Y | U | 0 | 850 | MG | ||||||
126161151 | 12616115 | 5 | SS | REPAGLINIDE. | REPAGLINIDE | 1 | Unknown | 3 X 1 MG/DAY | Y | U | 0 | 1 | MG | ||||||
126161151 | 12616115 | 6 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 40 MG/DAY | U | 0 | 40 | MG | |||||||
126161151 | 12616115 | 7 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | 75 MG/DAY | U | 0 | 75 | MG | |||||||
126161151 | 12616115 | 8 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | 25 MG/DAY | Y | 0 | 25 | MG | |||||||
126161151 | 12616115 | 9 | SS | BISOPROLOL | BISOPROLOL | 1 | Unknown | 2.5 MG/DAY | Y | 0 | 2.5 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126161151 | 12616115 | 1 | Product used for unknown indication |
126161151 | 12616115 | 2 | Product used for unknown indication |
126161151 | 12616115 | 3 | Product used for unknown indication |
126161151 | 12616115 | 4 | Product used for unknown indication |
126161151 | 12616115 | 5 | Product used for unknown indication |
126161151 | 12616115 | 6 | Product used for unknown indication |
126161151 | 12616115 | 7 | Product used for unknown indication |
126161151 | 12616115 | 8 | Product used for unknown indication |
126161151 | 12616115 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126161151 | 12616115 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126161151 | 12616115 | Acute kidney injury | |
126161151 | 12616115 | Fatigue | |
126161151 | 12616115 | Sinus bradycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |